JPRN-jRCT1080224720已完成未知
TR research associated with 'A multicenter Phase II basket-type clinical trial to evaluate efficacy and safety of TAS-120 in patients with advanced solid malignancies with FGFR alterations in circulating tumor DNA (TiFFANY study)'
ational Cancer Center Hospital East0 个研究点目标入组 26 人开始时间: 2019年6月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients enrolled in treatment group in 'A multicenter Phase II basket-type clinical trial to evaluate efficacy and safety of TAS-120 in patients with advanced solid malignancies with FGFR alterations in circulating tumor DNA(TiFFANY study)'
排除标准
- 未提供
研究者
相似试验
已完成
不适用
TR study of "A multicenter phase II study of eribulin monotherapy in patients with BRAF V600E mutant metastatic colorectal cancer (BRAVERY study)"BRAF V600E mutant metastatic colorectal cancerJPRN-UMIN000031552Aichi Cancer Center Hospital27
已完成
不适用
Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast Cancer-C509 Breast, unspecifiedBreast, unspecifiedC509PER-009-06GLAXOSMITHKLINE BIOLOGICALS,
已完成
不适用
TR study of "multicenter Phase II study to evaluate efficacy and safety of combination therapy with trastuzumab and pertuzumab in patients with HER2-positive metastatic colorectal cancer"colorectal cancerJPRN-UMIN000030505ational Cancer Center Hospital East30
招募中
1 期
A phase Ib/II, multicenter study to investigate the safety, efficacy, and proof-of-concept (POC) of nivolumab monotherapy as a sequential therapy following preoperative chemoradiotherapy in patients with locally advanced resectable rectal cancerRectal cancerJPRN-UMIN000023148ational Cancer CenterHospital East50
已完成
1 期
Phase Ia/Ib multicenter investigator initiated trial of Mogamulizumab for advanced or recurrent cancer.Advanced or recurrent cancerJPRN-UMIN000010050Aichi Medical University School of Medicine, Department of Tumor Immunology58